James V Cassella is Chief Development Officer of Concert Pharmaceuticals Inc.
Person profile
Roles
Concert Pharmaceuticals
Chief Development Officer
Address
Mountain View, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Trevi Therapeutics, Inc.
14 Jun 24
4
Trevi Therapeutics, Inc.
30 Jun 23
4
CONCERT PHARMACEUTICALS, INC.
6 Mar 23
4
CONCERT PHARMACEUTICALS, INC.
16 Feb 23
4
CONCERT PHARMACEUTICALS, INC.
31 Jan 23
4
CONCERT PHARMACEUTICALS, INC.
9 Jan 23
4/A
Trevi Therapeutics, Inc.
1 Jul 22
4
Trevi Therapeutics, Inc.
23 Jun 22
4
CONCERT PHARMACEUTICALS, INC.
16 Feb 22
4
CONCERT PHARMACEUTICALS, INC.
1 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | TRVI Trevi Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 2.77 | 30,000 | 83.10 k | 30,000 |
28 Jun 23 | TRVI Trevi Therapeutics | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 2.27 | 30,000 | 68.10 k | 30,000 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Common Stock | Sale back to company | Dispose D | No | No | 0 | 57,766 | 0.00 | 0 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 80,595 | 0.00 | 0 | |
6 Mar 23 | CNCE Concert Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.07 | 60,400 | 789.43 k | 0 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 10.87 | 42,430 | 461.21 k | 0 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 13.93 | 75,000 | 1.04 mm | 0 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 27.59 | 49,500 | 1.37 mm | 0 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 10.97 | 70,000 | 767.90 k | 0 |
6 Mar 23 | CNCE Concert Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.85 | 50,000 | 842.50 k | 0 |